Publication
Cost-Effectiveness of Autologous Stem Cell Transplantation in Multiple Myeloma Patients Aged 65 to 69 Years (CAREMM-2110 Study).
Jung Yeon Lee, Seungpil Jung, Sung-Soo Park, Seonggyu Byeon, Seung-Hwan Shin, Young-Woo Jeon, Seung-Ah Yahng, Suein Choi, Jin Seok Kim, Chang-Ki Min
- Source
- PubMed
- Retrieved
- Sep 13, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260913-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
OBJECTIVES: Autologous stem cell transplantation (ASCT) remains a cornerstone therapy for eligible patients with multiple myeloma (MM), but its use in older adults is debated because of concerns about toxicity and cost-effectiveness (CE). This study aimed to evaluate the CE of upfront ASCT compared…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMultiple Myelomadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available